Franchise Clinical Operations Development Lead; CODL

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

• Oversee the CODLs who provide strategic input and are accountable for all clinical related aspects within the assigned therapeutic indication/program, in line with the agreed timelines, budget and quality standards and as outlined in the applicable Standard Operation Procedures (SOPs) and Work Instructions (WIs).
• Oversee the Clinical development Plan (CDP) creation for all indications within the franchise. The CDP is co-created by the CODL and the Medical Development Lead (MDL), with support from the Project Manager (PM) and other Clinical Development Team (CDT) representatives. The indication CDP describes the clinical development strategy, includes effective and, where possible, innovative trial designs and is consistent with the TPP.
  
  The CDP is endorsed by the Asset Strategy Team (AST) and the Development Management Committee (DMC) and is executed within agreed timelines and budget
• The Franchise CODL can temporarily take on the role of an CODL for an indication within the franchise. Please refer to the Job Description of the CODL for further details on the CODL role.
• Acts as senior point of contact for all clinical related activities for a given Franchise across asset indications. Collaborate with the asset teams as applicable.
• Focus on risks and mitigations on the franchise level. Ensures that the Global Head of Trial Operations is informed in case an identified issue/risk could have an impact on/may also occur in, the other therapeutic indications/programs / franchises. Involve the X-indication CODL, AST and PM as needed.
• Operationalize knowhow and synergies at the franchise level, ensure knowhow is shared with different indication teams.
• Ensure optimal implementation of lessons learnt within and across the franchises.
• Provides input to the relevant Objectives, Goals, Strategies and Measures (OGSMs), and ensures that clinical trials are executed according to the CDPs and those OGSMs, following the argenx procedures and processes and conducted in compliance with ICH-GCP and other applicable legislation.
• As needed, participates in the Clinical Research Organization (CRO) and vendor selection and management process. Supports CDTs and Clinical Trial Teams (CTTs) with issue resolution where required in collaboration with the CODL and alliance vendor manager, if relevant.
• Acts as a point of escalation for resolution of trial management and operational issues within the franchise indications.
• Reviews and provides input to the overarching clinical program/indication documents such as Investigator Brochure (IB), Pediatric Investigation Plan (PIP), FDA/PMDA/EMA and other regulatory critical documents.
• Oversees the Indication and clinical trial budgets and timelines in collaboration with the CODLs and the Clinical Trial Managers (CTMs).
• Oversees the resource requirements for Trial Operations within the franchise and ensures the needed resources are onboarded timely and efficiently.
• Oversees audit/inspection readiness of the assigned program/trials.…